A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

NCT00377988 · clinicaltrials.gov ↗

COMPLETED

Status

423

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception
Female Contraception

Interventions

DRUG: Transdermal Contraceptive System
DRUG: Norgestimate-containing oral contraceptives with EE

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.